Skip to search formSkip to main contentSkip to account menu

Deoxyadenosine/Creatinine:SRto:Pt:Urine:Qn

Known as: Deoxiadenosina/Creatinina:SRto:Punto temporal:Orina:Qn, Deoxyadenosine/Creat Ur-sRto, Deoxyadenosine/Creatinine:Substance Ratio:Point in time:Urine:Quantitative 
National Institutes of Health

Related topics

Related topics

5 relations
2'-deoxyadenosineChemical procedureCreatinineSubstance Ratio

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Analysis of dibenzo[def,p]chrysene-deoxyadenosine adducts in wild-type and cytochrome P450 1b1 knockout mice using stable-isotope dilution UHPLC-MS/MS.
2010
2010
Exocyclic deoxyadenosine adducts of 1,2,3,4-diepoxybutane: synthesis, structural elucidation, and mechanistic studies.
1,2,3,4-Diepoxybutane (DEB) is considered the ultimate carcinogenic metabolite of 1,3-butadiene, an important industrial chemical… 
2006
2006
Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
Highly Cited
2002
Highly Cited
2002
Adenosine deaminase deficiency with mosaicism for a "second-site suppressor" of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy.
Four patients from 3 Saudi Arabian families had delayed onset of immune deficiency due to homozygosity for a novel intronic… 
2001
2001
Molecular Basis for Paradoxical Carriers of Adenosine Deaminase (ADA) Deficiency That Show Extremely Low Levels of ADA Activity in Peripheral Blood Cells Without Immunodeficiency1
Adenosine deaminase (ADA) deficiency causes an autosomal recessive form of severe combined immunodeficiency and also less severe… 
Highly Cited
1999
Highly Cited
1999
Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.
The P2Y1 receptor is present in the heart, in skeletal and various smooth muscles, and in platelets, where its activation is… 
1997
1997
Comparison of the morphological transforming activities of dibenzo[a,l]pyrene and benzo[a]pyrene in C3H10T1/2CL8 cells and characterization of the dibenzo[a,l]pyrene-DNA adducts.
C3H10T1/2CL8 (C3H10T1/2) mouse embryo fibroblasts were used to study the in vitro carcinogenic activities of dibenzo[a,l]pyrene… 
1995
1995
Stereoselectivity of activation of 7,12-dimethylbenz[a]anthracene- 3,4-dihydrodiol to the anti-diol epoxide metabolite in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay.
7,12-Dimethylbenz[a]anthracene (DMBA), one of the most carcinogenic polycyclic aromatic hydrocarbons in rodent bioassays, is… 
Highly Cited
1984
Highly Cited
1984
The stereochemical course of the restriction endonuclease EcoRI-catalyzed reaction.
The restriction endonuclease EcoRI hydrolyzes the Rp diastereomer of d(pGGsAATTCC), an analogue of d(pGGAATTCC) containing a… 
Highly Cited
1983
Highly Cited
1983
Products of binding of 7,12-dimethylbenz(a)anthracene to DNA in mouse skin.
7,12-Dimethylbenz(a)anthracene (DMBA):deoxyribonucleoside-adducts, from enzymatic hydrolysis of DNA from mouse skin exposed to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)